These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A positron emission tomography study examining the dopaminergic activity of armodafinil in adults using [¹¹C]altropane and [¹¹C]raclopride. Spencer TJ, Madras BK, Bonab AA, Dougherty DD, Clarke A, Mirto T, Martin J, Fischman AJ. Biol Psychiatry; 2010 Nov 15; 68(10):964-70. PubMed ID: 21035624 [Abstract] [Full Text] [Related]
5. Evaluating dopamine reward pathway in ADHD: clinical implications. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM. JAMA; 2009 Sep 09; 302(10):1084-91. PubMed ID: 19738093 [Abstract] [Full Text] [Related]
6. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH. Biol Psychiatry; 2012 Sep 01; 72(5):405-13. PubMed ID: 22537794 [Abstract] [Full Text] [Related]
7. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM. Arch Gen Psychiatry; 2007 Aug 01; 64(8):932-40. PubMed ID: 17679638 [Abstract] [Full Text] [Related]
8. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, Baumann MH. J Pharmacol Exp Ther; 2009 May 01; 329(2):738-46. PubMed ID: 19197004 [Abstract] [Full Text] [Related]
9. In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [¹⁸F]FE-PE2I. Kim W, Tateno A, Arakawa R, Sakayori T, Ikeda Y, Suzuki H, Okubo Y. Int J Neuropsychopharmacol; 2014 May 01; 17(5):697-703. PubMed ID: 24451483 [Abstract] [Full Text] [Related]
10. Sex differences in dopamine binding and modafinil conditioned place preference in mice. Bernardi RE, Broccoli L, Spanagel R, Hansson AC. Drug Alcohol Depend; 2015 Oct 01; 155():37-44. PubMed ID: 26342627 [Abstract] [Full Text] [Related]
14. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, Slifstein M, Van Heertum R, Kleber HD. Am J Psychiatry; 2009 Oct 01; 166(10):1170-7. PubMed ID: 19723785 [Abstract] [Full Text] [Related]
15. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Costa D, Perry RH, Perry EK. Neuroscience; 1999 May 01; 90(2):433-45. PubMed ID: 10215149 [Abstract] [Full Text] [Related]
17. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release. Volkow ND, Wang GJ, Smith L, Fowler JS, Telang F, Logan J, Tomasi D. Neuroimage; 2015 Nov 01; 121():20-8. PubMed ID: 26208874 [Abstract] [Full Text] [Related]
20. Dopaminergic role in stimulant-induced wakefulness. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. J Neurosci; 2001 Mar 01; 21(5):1787-94. PubMed ID: 11222668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]